Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Aspirin in Subclinical Coronary Artery Disease: A Pilot Randomised Controlled Trial

NCT07524335 is registered in ClinicalTrials.gov with Montreal Heart Institute as lead sponsor.

NCT NCT07524335
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07524335 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Aspirin in Subclinical Coronary Artery Disease: A Pilot Randomised Controlled Trial
Lead sponsor
Montreal Heart Institute
Phase
Phase 3
Overall status
Recruiting
Start date
July 21, 2026
Completion date
January 31, 2028
Enrollment
48 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease, subclinical atherosclerotic cardiovascular disease